Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage MITQ Q1 2026 Earnings Narrowed Loss Reflects Operational Discipline KNTK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines IN8bio Q1 2026 Earnings Narrowed Loss Beats Expectations as Development Pipeline Advances DMC Global BOOM Q1 2026 Earnings Surprise EPS Beat Amid Persistent Headwinds DVLT Q1 2026 Earnings EPS Misses Estimates Stock Declines